Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip C Calder

Showing results (131-140 of 581) with videos related to

Pageof 59
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|February 6, 2025
Lipid metabolism and therapy: another year of exciting advancesDan L Waitzberg, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|February 7, 2020
Editorial: Is it time to separate EPA from DHA when using omega-3 fatty acids to protect heart and brain?Richard J Deckelbaum, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|February 12, 2011
Harmful, harmless or helpful? The n-6 fatty acid debate goes onPhilip C Calder, Richard J Deckelbaum
The British Journal of Nutrition|May 18, 2012
Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritisElizabeth A Miles, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|December 27, 2018
Editorial: Omega-3 fatty acids and cardiovascular outcomes: an updatePhilip C Calder, Richard J Deckelbaum
Current Opinion in Clinical Nutrition and Metabolic Care|January 18, 2013
Intravenous fish oil in hospitalized adult patients: reviewing the reviewsPhilip C Calder, Richard J Deckelbaum
Current Opinion in Clinical Nutrition and Metabolic Care|December 22, 2011
Different outcomes for omega-3 heart trials: why?Richard J Deckelbaum, Philip C Calder
Current Pharmaceutical Design|May 25, 2013
Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhoodElizabeth A Miles, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|February 5, 2026
Lipids as biological response modifiers: from epidemiology to molecular mechanismsDan L Waitzberg, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|January 23, 2014
Dietary fatty acids in health and disease: greater controversy, greater interestPhilip C Calder, Richard J Deckelbaum
Pageof 59

Showing results (131-140 of 581) with videos related to

Sort By:
Pageof 59
Current Opinion in Clinical Nutrition and Metabolic Care|February 6, 2025
Lipid metabolism and therapy: another year of exciting advancesDan L Waitzberg, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|February 7, 2020
Editorial: Is it time to separate EPA from DHA when using omega-3 fatty acids to protect heart and brain?Richard J Deckelbaum, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|February 12, 2011
Harmful, harmless or helpful? The n-6 fatty acid debate goes onPhilip C Calder, Richard J Deckelbaum
The British Journal of Nutrition|May 18, 2012
Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritisElizabeth A Miles, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|December 27, 2018
Editorial: Omega-3 fatty acids and cardiovascular outcomes: an updatePhilip C Calder, Richard J Deckelbaum
Current Opinion in Clinical Nutrition and Metabolic Care|January 18, 2013
Intravenous fish oil in hospitalized adult patients: reviewing the reviewsPhilip C Calder, Richard J Deckelbaum
Current Opinion in Clinical Nutrition and Metabolic Care|December 22, 2011
Different outcomes for omega-3 heart trials: why?Richard J Deckelbaum, Philip C Calder
Current Pharmaceutical Design|May 25, 2013
Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhoodElizabeth A Miles, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|February 5, 2026
Lipids as biological response modifiers: from epidemiology to molecular mechanismsDan L Waitzberg, Philip C Calder
Current Opinion in Clinical Nutrition and Metabolic Care|January 23, 2014
Dietary fatty acids in health and disease: greater controversy, greater interestPhilip C Calder, Richard J Deckelbaum
Pageof 59